Comparison results
| Results: Differences General | ✘The Arthus Phenomenon | ✘Gonorrheal vulvovaginitis | |||||||||||||
| Related research | Analogs | Analogs | |||||||||||||
| |||||||||||||||
| Distinctive symptoms | |||||||||||||||
| Register, to see more distinctive signs of diseases and studies | 43% | — | |||||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||||||||
| hyperchromia | 38% | — | |||||||||||||
| gonorrheal vulvovaginitis | — | 94% | |||||||||||||
| the arthus phenomenon | 37% | — | |||||||||||||
| gonorrhea | — | 75% | |||||||||||||
| increased ast | 34% | — | |||||||||||||
| vulvovaginitis | — | 56% | |||||||||||||
| leukocyturia | 31% | — | |||||||||||||
| vulva infections | — | 56% | |||||||||||||
| proteinuria | 28% | — | |||||||||||||
| redness of the vulva | — | 43% | |||||||||||||
| with reactive protein increased | 24% | — | |||||||||||||
| discharge from the urethra | — | 37% | |||||||||||||
| protein with increased | 21% | — | |||||||||||||
| urethral syndrome | — | 37% | |||||||||||||
| drug allergy | 18% | — | |||||||||||||
| swelling with itching | — | 35% | |||||||||||||
| intolerance to drugs | 18% | — | |||||||||||||
| hyperemia of genitals | — | 34% | |||||||||||||
| increased sensitivity | 18% | — | |||||||||||||
| sensitivity of mucous membranes | — | 32% | |||||||||||||
| allergy | 17% | — | |||||||||||||
| postmenopause | — | 31% | |||||||||||||
| necrosis | 17% | — | |||||||||||||
| conjunctivitis | — | 30% | |||||||||||||
| drug disease | 16% | — | |||||||||||||
| childhood diseases | — | 29% | |||||||||||||
| main complaint is allergy | 15% | — | |||||||||||||
| peritonitis | — | 28% | |||||||||||||
| allergy to antibiotics | 15% | — | |||||||||||||
| arthritis | — | 25% | |||||||||||||
| lot of plans | 13% | — | |||||||||||||
| joint diseases | — | 23% | |||||||||||||
| leukocytosis | 12% | — | |||||||||||||
| inflammation | 7% | 28% | |||||||||||||
| controls itself | 12% | — | |||||||||||||
| unbearable pain | 9% | 27% | |||||||||||||
| severe itching of the skin | 11% | — | |||||||||||||
| itchy skin | 12% | 25% | |||||||||||||
| dense swelling | 11% | — | |||||||||||||
| soreness of the skin | 11% | 23% | |||||||||||||
| wound | 11% | — | |||||||||||||
| acute pain | 11% | 22% | |||||||||||||
| consequence of hormone treatment | 11% | — | |||||||||||||
| swelling | 10% | 21% | |||||||||||||
| consequences of taking medications | 10% | — | |||||||||||||
| lowered | 12% | 19% | |||||||||||||
| serum sickness | 10% | — | |||||||||||||
| increased | 15% | 19% | |||||||||||||
| effects of taking hormones | 10% | — | |||||||||||||
| indecision | 10% | — | |||||||||||||
| changes in urine | 10% | — | |||||||||||||
| skin problems | 10% | — | |||||||||||||
| dermatosis | 10% | — | |||||||||||||
| allergy to the skin | 10% | — | |||||||||||||
| feeling lonely | 10% | — | |||||||||||||
| I can't be alone | 9% | — | |||||||||||||
| oily skin | 9% | — | |||||||||||||
| scratch | 9% | — | |||||||||||||
| wounds heal poorly | 9% | — | |||||||||||||
| vaccination | 9% | — | |||||||||||||
| rapid reaction | 9% | — | |||||||||||||
| allergy to medications | 9% | — | |||||||||||||
| muscle damage | 9% | — | |||||||||||||
| history of surgery | 9% | — | |||||||||||||
| surgical infections | 8% | — | |||||||||||||
| headaches | 8% | — | |||||||||||||
| diabetes mellitus | 8% | — | |||||||||||||
| blood diseases | 7% | — | |||||||||||||
| patient's condition | 7% | — | |||||||||||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
